POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 38 | / | 2014 | ||||||||
Date of issue: | |||||||||||
Short name of the issuer | |||||||||||
KRKA | |||||||||||
Subject | |||||||||||
Change of major shareholdings | |||||||||||
Official market - legal basis | |||||||||||
Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
Krka, d. d., Novo mesto (hereafter Krka) announces that it has received notifications on changes of major shareholdings on 10 July 2014 from Slovenski dr¾avni holding, d. d. and on 8 July 2014 from Kapitalska dru¾ba pokojninskega in invalidskega zavarovanja d. d. According to the decision of 19th Annual General Meeting of Krka shareholders from 3 July 2014 on decrease of share capital by cancelation of treasury shares, major shareholding of Slovenski dr¾avni holding, d. d., Mala ulica 5, Ljubljana increased from 14.99% to 16.20%, where the number of Krka shares held by this shareholder is unchanged, and major shareholding of Kapitalska dru¾ba pokojninskega in invalidskega zavarovanja d. d., Dunajska cesta 119, Ljubljana increased from 9.86% to 10.652%, where the number of Krka shares held by this shareholder is unchanged. | |||||||||||
Annexes | |||||||||||
File | Description |
KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
(fullname of the issuer) | |||||||||||||
KRKA | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
8501 | Nove Mesto | ||||||||||||
(post code) | (city) | ||||||||||||
Smarjeska | 6 | ||||||||||||
(street) | (number) | ||||||||||||
+386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
SI82646716 | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2014-07-10 | Jo¾e Colariè | President of the Management Board2 |